Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Neural effects of psilocybin-treatment in patients with treatment-resistant depression

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal
Neuroscience Applied
Date
2023-12-31
Source
OpenAlex
DOI
10.1016/j.nsa.2024.105028
PubMed
Unavailable

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Related papers

Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-02-24Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-reportJournal of Parkinson s Disease · 2025-02-01The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted ClinicalJOURNAL OF ADVANCE AND FUTURE RESEARCH · 2026-04-30THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERSInternational Journal of Innovative Technologies in Social Science · 2026-01-22Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24